IGENE THERAPEUTICS
iGENE Therapeutics, Inc. operates as a biotechnology company in the field of drug discovery. The company was founded in 2003 and is based in Tsukuba, Japan. As of May 1, 2008, iGENE Therapeutics, Inc. operates as a subsidiary of Nagase & Co. Ltd.
IGENE THERAPEUTICS
Industry:
Biotechnology Life Science Manufacturing Therapeutics
Founded:
2003-01-01
Address:
Tsukuba, Ibaraki, Japan
Country:
Japan
Website Url:
http://www.igene-therapeutics.co.jp
Status:
Closed
Contact:
03-3665-3143
Technology used in webpage:
Domain Not Resolving
Official Site Inspections
http://www.igene-therapeutics.co.jp
Unable to get host informations!!!
More informations about "iGENE Therapeutics"
iGENE Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore iGENE Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
iGENE Therapeutics
IGENE Therapeutics, Inc. operates as a biotechnology company in the field of drug discovery. The company was founded in 2003 and is based in Tsukuba, Japan. As of May 1, 2008, iGENE …See details»
IGENE Therapeutics - Company Profile - Tracxn
Oct 19, 2024 IGENE Therapeutics ranks 1,740th among 2100 active competitors. 514 of its competitors are funded while 352 have exited. Overall, IGENE Therapeutics and its …See details»
iGENE Therapeutics - Apollo.io
IGENE Therapeutics, Inc. operates as a biotechnology company in the field of drug discovery. The company was founded in 2003 and is based in Tsukuba, Japan. As of May 1, 2008, iGENE …See details»
Nagase & Co acquires iGENE Therapeutics - 2008-05-01
IGENE Therapeutics Nagase & Co manufactures, imports, and exports chemicals, plastics, electronics materials, cosmetics, and health foods worldwide. Acquiring Organization: Nagase …See details»
iGENE Therapeutics - Crunchbase
Organization. iGENE Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. ... iGENE Therapeutics and China …See details»
IGENE Therapeutics - Company Profile - Tracxn
IGENE Therapeutics - Gene therapy based drug discovery. Acquired by NAGASE. IGENE Therapeutics has 2845 competitors.See details»
iGENE Therapeutics company information, funding & investors
IGENE Therapeutics, nagase & co manufactures, imports, and exports chemicals, plastics, electronics materials, cosmetics, and health foods worldwide. Here you'll find information …See details»
i-Gene Company Profile 2024: Valuation, Funding & Investors
I-Gene General Information Description. Developer of technology intended for gene transfer and molecular introduction. The company specializes in atmospheric pressure plasma systems, …See details»
Genome‐wide application of RNAi to the discovery of potential …
Aug 22, 2005 iGENE Therapeutics Inc., Central 4, 1-1-1 Higashi, Tsukuba Science City 305-8562, Japan. Department of Chemistry and Biotechnology, School of Engineering, The …See details»
Small‐Interfering‐RNA Expression in Cells Based on an Efficiently ...
Jun 9, 2004 iGENE Therapeutics, Inc. Central 4, 1-1-1 Higashi, Tsukuba Science City 305-8562, Japan. Search for more papers by this author. Kazunari Taira Prof. Dr., Kazunari Taira Prof. …See details»
IGene Biotechnology - Company Profile - Tracxn
Oct 27, 2024 IGene Biotechnology ranks 880th among 880 competitors. 51 of its competitors are funded while 90 have exited. Overall, IGene Biotechnology and its competitors have raised …See details»
iGENE Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. iGENE Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. iGENE …See details»
PGE2 induces interleukin-8 derepression in human astrocytoma …
Nov 1, 2012 The histological grade of these tumors was classified according to the World Health Organization (WHO) criteria. Soon after any surgical removal, the specimens were frozen in …See details»
Effect of asymmetric terminal structures of short RNA duplexes on …
Sep 9, 2008 RNAs were designed and provided by iGENE Therapeutics Inc. (Tokyo, Japan). siRNA duplexes were prepared by mixing equimolar amounts of sense and antisense RNAs in …See details»
Analysis on a Cooperative Pathway Involving Multiple Cations in ...
Sep 11, 2004 Contribution from the Gene Function Research Center, National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba …See details»
Interspecies Single‐Cell RNA‐Seq Analysis Reveals the Novel …
Short hairpin RNA (shRNA) expression vectors were constructed using piGENEmU6 vector (iGENE Therapeutics, Tokyo, Japan), as described, (26) and the U6 promoter and inserts …See details»
iGENE Therapeutics - Updates, News, Events, Signals & Triggers
Nagase & Co manufactures, imports, and exports chemicals, plastics, electronics materials, cosmetics, and health foods worldwide.See details»
NIH, FDA and 15 private organizations join forces to increase …
The FNIH works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. Established by …See details»
Beam Therapeutics Announces New Data from BEACON Phase 1/2 …
1 day ago Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting …See details»